share_log

Analyst Ratings for IBEX

Benzinga ·  Sep 18, 2023 11:00

IBEX (NASDAQ:IBEX) has observed the following analyst ratings within the last quarter:

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings12200
Last 30D01000
1M Ago11200
2M Ago00000
3M Ago00000

According to 5 analyst offering 12-month price targets in the last 3 months, IBEX has an average price target of $20.2 with a high of $25.00 and a low of $17.00.

Below is a summary of how these 5 analysts rated IBEX over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

This current average has decreased by 24.63% from the previous average price target of $26.80.

Stay up to date on IBEX analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

What Are Analyst Ratings?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment